Skip to main navigation Skip to search Skip to main content

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer

  • Tomasz M Beer
  • , Eugene D Kwon
  • , Charles G Drake
  • , Karim Fizazi
  • , Christopher Logothetis
  • , Gwenaelle Gravis
  • , Vinod Ganju
  • , Jonathan Polikoff
  • , Fred Saad
  • , Piotr Humanski
  • , Josep M Piulats
  • , Pablo Gonzalez Mella
  • , Siobhan S Ng
  • , Dirk Jaeger
  • , Francis X Parnis
  • , Fabio A Franke
  • , Javier Puente
  • , Roman Carvajal
  • , Lisa Sengeløv
  • , M Brent McHenry
    • Arvind Varma, Alfonsus J van den Eertwegh, Winald Gerritsen

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science